A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymphoma

Clinical trial NCT04860674 · UNKNOWN

Trial details

NCT number: NCT04860674
Sponsor: Zhejiang Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Gray Zone Lymphoma Relapse/Recurrence Chemotherapy Effect

Start date: 2021-05-01
Primary completion: 2024-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.